This inventor holds 1 USPTO granted patent. Top assignee: Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: Hidetoshi Hakira: Innovator in Gastrointestinal Therapeutics
Introduction
Hidetoshi Hakira is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target gastrointestinal diseases. His work has implications for various therapeutic applications, showcasing his expertise and innovative spirit.
Latest Patents
Hakira holds a patent for "Benzoic acid compounds and use thereof as medicaments." This patent describes benzoic acid compounds that exhibit high and selective affinity for serotonin 4 receptors. These compounds are not only effective as gastrointestinal prokinetic agents but also serve as therapeutic agents for a range of gastrointestinal diseases, central nervous disorders, and other medical conditions. The patent highlights the potential of these compounds to act as analgesics by increasing the pain threshold.
Career Highlights
Hidetoshi Hakira is associated with Yoshitomi Pharmaceutical Industries, Ltd., where he continues to advance his research and development efforts. His work has led to the creation of innovative pharmaceutical compositions that incorporate his patented compounds. With a focus on improving patient outcomes, Hakira's contributions are vital to the pharmaceutical industry.
Collaborations
Hakira has collaborated with esteemed colleagues such as Shuji Sonda and Katsuhiko Ito. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic agents.
Conclusion
Hidetoshi Hakira's innovative work in the field of medicinal chemistry, particularly with his patented benzoic acid compounds, underscores his commitment to advancing healthcare solutions. His contributions are paving the way for new treatments for gastrointestinal diseases and beyond.